Clinical Trial Update: Calcinosis Cutis: Therapeutic Effects of Extracorporeal Shock Wave Therapy (ESWT) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing extracorporeal shock wave therapy (ESWT) for calcinosis cutis in connective tissue disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Calcinosis Cutis

Snippet

Sponsor: University of Zurich | Conditions: Calcinosis Cutis in Connective Tissue Disease | Phase 3 | Status: COMPLETED